Ceftriaxone 250 Mg & Tazobactam 31.25 Mg for Injection – Zonium -281.25 Injection

Ceftriaxone 250 Mg & Tazobactam 31.25 Mg for Injection Combining Strength and Resistance to Defeat for Effective Infection Control.

Zonium -281.25 Injection: The Dual combination of Ceftriaxone 250mg + Tazobactam 31.25mg combines Ceftriaxone, a third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor. Ceftriaxone inhibits bacterial cell wall synthesis, while Tazobactam protects it from enzymatic degradation, allowing for reliable treatment of various infections. The combination is beneficial in mixed and resistant infections.

Combines Ceftriaxone, a third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor. Ceftriaxone inhibits bacterial cell wall synthesis, while Tazobactam protects it from enzymatic degradation, allowing for reliable treatment of various infections. The combination is beneficial in mixed and resistant infections.

Recommended By Specialists:
General Physicians: It is preferred to treat the disease associated with mild bacterial infections
Pulmonologists: It is preferred to treat the disease associated with respiratory tract infections, including pneumonia

Key benefits of
Potent Combination Therapy – Ceftriaxone offers broad-spectrum coverage, while Tazobactam inhibits beta-lactamases, enhancing activity against resistant pathogens.
Effective Against Gram-Positive & Gram-Negative Infections: It acts against many bacteria, including beta-lactamase-producing organisms, ensuring greater clinical success in moderate infections.
Reduced Resistance & Superior Safety – Combines the proven safety profile of Ceftriaxone with Tazobactam’s resistance-fighting edge—minimizing treatment failure risk.

INDICATIONS:
Respiratory Tract Infections
Urinary Tract Infections
Skin & Soft Tissue Infections
Intra-abdominal Infections
Bone & Joint Infections